• 2491 Citations
  • 21 h-Index
19972019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Massimiliano Cazzaniga is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 16 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Tamoxifen Medicine & Life Sciences
exemestane Medicine & Life Sciences
Fenretinide Medicine & Life Sciences
Metformin Medicine & Life Sciences
Breast Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Placebos Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1997 2019

  • 2491 Citations
  • 21 h-Index
  • 70 Article
  • 2 Review article
  • 1 Comment/debate

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

Pizzuti, L., Krasniqi, E., Barchiesi, G., Della Giulia, M., Izzo, F., Sanguineti, G., Marchetti, P., Mazzotta, M., Giusti, R., Botticelli, A., Gamucci, T., Natoli, C., Grassadonia, A., Tinari, N., Iezzi, L., Tomao, S., Tomao, F., Tonini, G., Santini, D., Astone, A. & 30 others, Michelotti, A., De Angelis, C., Mentuccia, L., Vaccaro, A., Magnolfi, E., Gelibter, A., Magri, V., Cortesi, E., D'Onofrio, L., Cassano, A., Rossi, E., Cazzaniga, M., Moscetti, L., Omarini, C., Piacentini, F., Fabbri, M. A., Scinto, A. F., Corsi, D., Carbognin, L., Bria, E., La Verde, N., Garufi, C., Paris, I., Giotta, F., Lorusso, V., De Maria, R., Ciliberto, G., Sperduti, I., Barba, M. & Vici, P., Jan 1 2019, (Accepted/In press) In : International Journal of Cancer.

Research output: Contribution to journalArticle

Open Access

Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies

Cazzaniga, M. E., Verusio, C., Ciccarese, M., Fumagalli, A., Sartori, D., Valerio, M. R., Airoldi, M., Moretti, G., Ficorella, C., Gianni, L., Michelotti, A., Zambelli, A., Febbraro, A., Generali, D., Pistelli, M., Garrone, O., Musolino, A., Vici, P., Maur, M., Mentuccia, L. & 31 others, La Verde, N., Bianchi, G. V., Artale, S., Blasi, L., De Laurentiis, M., Atzori, F., Turletti, A., Porpiglia, M., Santini, D., Fabi, A., Gebbia, V., Schirone, A., Palumbo, R., Ferzi, A., Frassoldati, A., Scavelli, C., Clivio, L., Giordano, M., Donadio, M., Biganzoli, L., Del Mastro, L., Bisagni, G., Livi, L., Natoli, C., Montemurro, F., Riccardi, F., Romagnoli, E., Marchetti, P., Torri, V., Pronzato, P. & Mustacchi, G., Jan 1 2019, In : Breast Care.

Research output: Contribution to journalArticle

Extravehicular Activity
Breast Neoplasms
Therapeutics
Aromatase Inhibitors
Datasets
Open Access
eribulin
anthracyclines
Triple Negative Breast Neoplasms
taxanes
Catenins
4 Citations (Scopus)

Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity

the CI-PeriNomS Group, Mar 1 2019, In : Journal of the Peripheral Nervous System. 24, 1, p. 111-119 9 p.

Research output: Contribution to journalArticle

Physicians
Drug Therapy
Neurologic Examination
Vibration
Outcome Assessment (Health Care)
11 Citations (Scopus)
exemestane
letrozole
Tamoxifen
Aromatase Inhibitors
Breast Neoplasms